N-terminal pro –B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators

Sudden death risk stratification of patients with left ventricular systolic dysfunction remains challenging. Retrospective studies have suggested N-terminal pro –B-type natriuretic peptide (NT-proBNP) may be a useful risk stratification tool.

Source: Heart Rhythm - August 27, 2020 Category: Cardiology Authors: Jakub Sroubek, Jason Matos, Andrew Locke, Vladimir Kaplinskiy, Yehoshua C. Levine, Changyu Shen, Alfred E. Buxton Source Type: research